Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension

Aim. During 12-week perindopril (PR) and hypothiazide (HT) therapy, to study its antihypertensive efficacy, as well as its influence on endothelial function (EF) and angiotensin-converting enzyme (ACE) serum activity, in patents with essential arterial hypertension (EAH). Material and methods. The s...

Full description

Saved in:
Bibliographic Details
Main Authors: T. V. Aparina, A. N. Britov, O. A. Gomazkov, O. N. Yakimenko, T. V. Ektova, E. A. Dilakyan
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2005-06-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/963
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839578233047089152
author T. V. Aparina
A. N. Britov
O. A. Gomazkov
O. N. Yakimenko
T. V. Ektova
E. A. Dilakyan
author_facet T. V. Aparina
A. N. Britov
O. A. Gomazkov
O. N. Yakimenko
T. V. Ektova
E. A. Dilakyan
author_sort T. V. Aparina
collection DOAJ
description Aim. During 12-week perindopril (PR) and hypothiazide (HT) therapy, to study its antihypertensive efficacy, as well as its influence on endothelial function (EF) and angiotensin-converting enzyme (ACE) serum activity, in patents with essential arterial hypertension (EAH). Material and methods. The study included 20 males (mean age 48.8±8.4 years) with mild to moderate AH. Antihypertensive efficacy was assessed during office BP measurement (Korotkoff method) and 24-hour blood pressure monitoring (BPM). EF was assessed by endothelium-dependent vasodilatation (EDVD) during reactive hyperemia test (RHT). Results. According to office BP measurements, target BP level (<140/90 mm Hg) was achieved in 75% patients on PR monotherapy, and 65% on HT monotherapy. According to 24-hour BPM, PR influenced BP levels more beneficially than HT. During PR and HT monotherapy, antihypertensive effect was more pronounced in patients with moderate AH (p=0.06). PR monotherapy caused some EDVD increase in patients with moderate AH (by 10%; NS), but did not affect EDVD in individuals with mild AH. HT treatment substantially increased EDVD in patients with mild AH (by 24%, from 7.13 to 9.18) and even more in participants with moderate AH (by 54%, from 6.52 to 10.02). PR therapy significantly reduced ACE activity, increased at baseline, to 28.1 nmol/min•ml (-43%, p<0.01). In patients with initially low ACE activity, it remained at the same level (reduction to 21.16 nmol/min•ml, NS). HT treatment did not affect this parameter in participants with low or high initial ACE activity. Conclusion. PR and HT antihypertensive effects were associated with EDVD correction. PR and HT antihypertensive efficacy depended on baseline ACE activity. Both drugs could be used for BP correction in individuals with low ACE activity; for patients with initially high ACE activity, PR is more effective.
format Article
id doaj-art-8ac34b9c12e24e9d88cec2d0f73ee4a8
institution Matheson Library
issn 1728-8800
2619-0125
language Russian
publishDate 2005-06-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-8ac34b9c12e24e9d88cec2d0f73ee4a82025-08-04T12:50:09Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252005-06-0143, ч.I1723677Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertensionT. V. Aparina0A. N. Britov1O. A. Gomazkov2O. N. Yakimenko3T. V. Ektova4E. A. Dilakyan5State Research Center for Preventive Medicine, Ministry of Health of the Russian FederationState Research Center for Preventive Medicine, Ministry of Health of the Russian FederationV.N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Science, MoscowState Research Center for Preventive Medicine, Ministry of Health of the Russian FederationState Research Center for Preventive Medicine, Ministry of Health of the Russian FederationV.N. Orekhovich Research Institute of Biomedical Chemistry, Russian Academy of Medical Science, MoscowAim. During 12-week perindopril (PR) and hypothiazide (HT) therapy, to study its antihypertensive efficacy, as well as its influence on endothelial function (EF) and angiotensin-converting enzyme (ACE) serum activity, in patents with essential arterial hypertension (EAH). Material and methods. The study included 20 males (mean age 48.8±8.4 years) with mild to moderate AH. Antihypertensive efficacy was assessed during office BP measurement (Korotkoff method) and 24-hour blood pressure monitoring (BPM). EF was assessed by endothelium-dependent vasodilatation (EDVD) during reactive hyperemia test (RHT). Results. According to office BP measurements, target BP level (<140/90 mm Hg) was achieved in 75% patients on PR monotherapy, and 65% on HT monotherapy. According to 24-hour BPM, PR influenced BP levels more beneficially than HT. During PR and HT monotherapy, antihypertensive effect was more pronounced in patients with moderate AH (p=0.06). PR monotherapy caused some EDVD increase in patients with moderate AH (by 10%; NS), but did not affect EDVD in individuals with mild AH. HT treatment substantially increased EDVD in patients with mild AH (by 24%, from 7.13 to 9.18) and even more in participants with moderate AH (by 54%, from 6.52 to 10.02). PR therapy significantly reduced ACE activity, increased at baseline, to 28.1 nmol/min•ml (-43%, p<0.01). In patients with initially low ACE activity, it remained at the same level (reduction to 21.16 nmol/min•ml, NS). HT treatment did not affect this parameter in participants with low or high initial ACE activity. Conclusion. PR and HT antihypertensive effects were associated with EDVD correction. PR and HT antihypertensive efficacy depended on baseline ACE activity. Both drugs could be used for BP correction in individuals with low ACE activity; for patients with initially high ACE activity, PR is more effective.https://cardiovascular.elpub.ru/jour/article/view/963arterial hypertensionendothelium-dependent vasodilatationangiotensin-converting enzyme activity
spellingShingle T. V. Aparina
A. N. Britov
O. A. Gomazkov
O. N. Yakimenko
T. V. Ektova
E. A. Dilakyan
Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
Кардиоваскулярная терапия и профилактика
arterial hypertension
endothelium-dependent vasodilatation
angiotensin-converting enzyme activity
title Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
title_full Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
title_fullStr Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
title_full_unstemmed Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
title_short Perindopril and hydrochlorthiazide effects on endothelium-dependent vasodilatation and angiotensin-converting enzyme activity in patients with mild to moderate arterial hypertension
title_sort perindopril and hydrochlorthiazide effects on endothelium dependent vasodilatation and angiotensin converting enzyme activity in patients with mild to moderate arterial hypertension
topic arterial hypertension
endothelium-dependent vasodilatation
angiotensin-converting enzyme activity
url https://cardiovascular.elpub.ru/jour/article/view/963
work_keys_str_mv AT tvaparina perindoprilandhydrochlorthiazideeffectsonendotheliumdependentvasodilatationandangiotensinconvertingenzymeactivityinpatientswithmildtomoderatearterialhypertension
AT anbritov perindoprilandhydrochlorthiazideeffectsonendotheliumdependentvasodilatationandangiotensinconvertingenzymeactivityinpatientswithmildtomoderatearterialhypertension
AT oagomazkov perindoprilandhydrochlorthiazideeffectsonendotheliumdependentvasodilatationandangiotensinconvertingenzymeactivityinpatientswithmildtomoderatearterialhypertension
AT onyakimenko perindoprilandhydrochlorthiazideeffectsonendotheliumdependentvasodilatationandangiotensinconvertingenzymeactivityinpatientswithmildtomoderatearterialhypertension
AT tvektova perindoprilandhydrochlorthiazideeffectsonendotheliumdependentvasodilatationandangiotensinconvertingenzymeactivityinpatientswithmildtomoderatearterialhypertension
AT eadilakyan perindoprilandhydrochlorthiazideeffectsonendotheliumdependentvasodilatationandangiotensinconvertingenzymeactivityinpatientswithmildtomoderatearterialhypertension